Lower Risk of Cardiovascular (CV) Events and Death in Men Receiving ADT by Gonadotropin Releasing Hormone (GnRH) Antagonist, Degarelix, Compared with Luteinising Hormone-releasing (LHRH) Agonists
CUA Online Library. Klotz L. 06/25/13; 31329; MP-07.16
Disclosure(s): Study supported by Ferring Inc.
CLICK HERE TO LOGIN
REGULAR CONTENT
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}